BBT002
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BBT002, covering 2025-05-14 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) and Comorbid Asthma [Phase 1, Phase 2]